+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

North America Biosurgery Market (2019-2025)

  • ID: 4900440
  • Report
  • December 2019
  • Region: North America
  • 89 Pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • CSL Limited
  • Johnson and Johnson
  • Medtronic PLC
  • Pfizer, Inc.
  • Sanofi S.A.
The North America Biosurgery Market is expected to witness market growth of 6.4% CAGR during the forecast period (2019-2025).

Biosurgery is a biotherapy involving the introduction of life, disinfected maggots into the non-healing skin and soft tissue wound of a human or animal. It helps to clean out the necrotic tissue within a wound and disinfection. It was long believed that the debridement was selective on necrotic tissue, but new literature has questioned that belief. Fibrin and collagen sealant, hemostats, soft tissue attachments, adhesion barriers, and bone morphogenetic proteins are among the prevalent biosurgery products. The extensive investments by governments have improved healthcare facilities; this is expected to significantly expand the market. Biosurgery has provided a new potential in regenerative healing with the right combination of synthetics and biologics. The introduction of multi-use products arising from intensive research from major life sciences players has paved the way for lucrative prospects in the biosurgery market. Healthcare players are actively focused on boosting the new prospect of the market by developing novel biomaterials.

The scenario of the biosurgery market across American countries is influenced by the increased sport-related injuries and spinal injuries. Certain factors driving the market growth are the rise in per capita healthcare spending, the increase in the number of surgeries due to an increase in the obese population along with lifestyle disorders. Despite the numerous benefits, market growth is still hampered by factors such as high costs, and consumers ' growing preference for minimally invasive surgery as opposed to conventional surgery.

Based on Application, the market is segmented into General Surgeries, Orthopedic Surgeries, Neurological Surgeries, Cardiovascular Surgeries and Other Applications. Based on Product, the market is segmented into Surgical sealants, Soft Tissue Attachments, Adhesion Barriers, Hemostatic Agents, Bone Graft Substitutes and Other Products. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Baxter International, Inc., Johnson and Johnson, Medtronic PLC, Pfizer, Inc., Stryker Corporation, B. Braun Melsungen AG, Sanofi S.A., Becton, Dickinson and Company, Integra LifeSciences Holdings Corporation and CSL Limited.

Scope of the Study

Market Segmentation:

By Application
  • General Surgeries
  • Orthopedic Surgeries
  • Neurological Surgeries
  • Cardiovascular Surgeries
  • Other Applications

By Product
  • Surgical Sealants
  • Soft Tissue Attachments
  • Adhesion Barriers
  • Hemostatic Agents
  • Bone Graft Substitutes
  • Other Products

By Country
  • US
  • Canada
  • Mexico
  • Rest of North America

Companies Profiled
  • Baxter International, Inc.
  • Johnson and Johnson
  • Medtronic PLC
  • Pfizer, Inc.
  • Stryker Corporation
  • B. Braun Melsungen AG
  • Sanofi S.A.
  • Becton, Dickinson and Company
  • Integra LifeSciences Holdings Corporation
  • CSL Limited

Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • CSL Limited
  • Johnson and Johnson
  • Medtronic PLC
  • Pfizer, Inc.
  • Sanofi S.A.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Biosurgery Market, by Application
1.4.2 North America Biosurgery Market, by Product
1.4.3 North America Biosurgery Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition and Mergers : 2019-Dec - 2016-Apr) Leading Players
Chapter 4. North America Biosurgery Market by Application
4.1 North America General Surgeries Market by Country
4.2 North America Orthopedic Surgeries Market by Country
4.3 North America Neurological Surgeries Market by Country
4.4 North America Cardiovascular Surgeries Market by Country
4.5 North America Other Application Biosurgery Market by Country
Chapter 5. North America Biosurgery Market by Product
5.1 North America Surgical sealants Biosurgery Market by Country
5.2 North America Soft Tissue Attachments Biosurgery Market by Country
5.3 North America Adhesion Barriers Biosurgery Market by Country
5.4 North America Hemostatic Agents Biosurgery Market by Country
5.5 North America Bone Graft Substitutes Biosurgery Market by Country
5.6 North America Others Biosurgery Market by Country
Chapter 6. North America Biosurgery Market by Country
6.1 US Biosurgery Market
6.1.1 US Biosurgery Market by Application
6.1.2 US Biosurgery Market by Product
6.2 Canada Biosurgery Market
6.2.1 Canada Biosurgery Market by Application
6.2.2 Canada Biosurgery Market by Product
6.3 Mexico Biosurgery Market
6.3.1 Mexico Biosurgery Market by Application
6.3.2 Mexico Biosurgery Market by Product
6.4 Rest of North America Biosurgery Market
6.4.1 Rest of North America Biosurgery Market by Application
6.4.2 Rest of North America Biosurgery Market by Product
Chapter 7. Company Profiles
7.1 Baxter International, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Acquisition and Mergers:
7.2 Johnson and Johnson
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental &Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.5.2 Product Launches and Product Expansions:
7.3 Medtronic PLC
7.3.1 Company overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.4 Pfizer, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and Mergers:
7.5 Stryker Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and Mergers:
7.5.5.2 Product Launches and Product Expansions:
7.6 B. Braun Melsungen AG
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.7 Sanofi S.A.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Geographical Expansions:
7.8 Becton, Dickinson and Company
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and Mergers:
7.9 Integra LifeSciences Holdings Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and Mergers:
7.1 CSL Limited
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
Note: Product cover images may vary from those shown
  • Baxter International, Inc.
  • Johnson and Johnson
  • Medtronic PLC
  • Pfizer, Inc.
  • Stryker Corporation
  • B. Braun Melsungen AG
  • Sanofi S.A.
  • Becton, Dickinson and Company
  • Integra LifeSciences Holdings Corporation
  • CSL Limited
Note: Product cover images may vary from those shown

Loading
LOADING...